Canada Approves New Patent Covering Ibudilast’s Use for ALS Treatment
MecidiNova has received a notice of allowance for a patent application submitted with the Canadian regulatory agency for ibudilast as treatment for ALS.
19 Comments
Canada Approves New Patent Covering Ibudilast’s Use for ALS Treatment
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed